N

Noile-Immune Biotech Inc
TSE:4893

Watchlist Manager
Noile-Immune Biotech Inc
TSE:4893
Watchlist
Price: 156 JPY -2.5%
Market Cap: 6.8B JPY
Have any thoughts about
Noile-Immune Biotech Inc?
Write Note

Relative Value

The Relative Value of one Noile-Immune Biotech Inc stock under the Base Case scenario is 81.91 JPY. Compared to the current market price of 156 JPY, Noile-Immune Biotech Inc is Overvalued by 47%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
81.91 JPY
Overvaluation 47%
Relative Value
Price
N
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
9
vs Industry
24
Median 3Y
32.9
Median 5Y
32.9
Industry
7.6
Forward
21.5
vs History
vs Industry
Median 3Y
-8.6
Median 5Y
-8.6
Industry
22.1
Forward
-7.5
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-9.6
Industry
21.9
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-9.6
Industry
23.4
vs History
70
vs Industry
40
Median 3Y
1.7
Median 5Y
1.7
Industry
2.5
vs History
9
vs Industry
27
Median 3Y
20.1
Median 5Y
20.1
Industry
7.5
Forward
6.9
vs History
9
vs Industry
24
Median 3Y
20.3
Median 5Y
20.3
Industry
9.3
vs History
vs Industry
23
Median 3Y
-4
Median 5Y
-4
Industry
4.2
Forward
-2.6
vs History
vs Industry
22
Median 3Y
-4
Median 5Y
-4
Industry
4
vs History
vs Industry
27
Median 3Y
-4.1
Median 5Y
-4.1
Industry
5.9
vs History
vs Industry
23
Median 3Y
-4.1
Median 5Y
-4.1
Industry
3.9
vs History
75
vs Industry
9
Median 3Y
16.3
Median 5Y
16.3
Industry
4.5

Multiples Across Competitors

Competitors Multiples
Noile-Immune Biotech Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Noile-Immune Biotech Inc
TSE:4893
6.9B JPY 853.4 -6.5 -1.9 -1.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 027 714.7 -180 740.1 -219 476 -216 971.5
US
Abbvie Inc
NYSE:ABBV
310.3B USD 5.6 61.1 15.2 23.4
US
Amgen Inc
NASDAQ:AMGN
141.6B USD 4.4 33.5 16 30.4
US
Gilead Sciences Inc
NASDAQ:GILD
115.3B USD 4.1 915.4 10.2 10.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD 9.6 -213.4 21 22.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 852.6 -472.7 -514.8 -501.1
AU
CSL Ltd
ASX:CSL
134.4B AUD 5.7 31.8 19.7 24.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD 5.6 16.6 15.1 16.7
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.7 -58.8 -53
NL
argenx SE
XBRU:ARGX
35.8B EUR 19.2 -134.7 -108.7 -79.3
P/S Multiple
Revenue Growth P/S to Growth
JP
N
Noile-Immune Biotech Inc
TSE:4893
Average P/S: 3 457 317.5
853.4
2%
503.3
FR
Pharnext SCA
OTC:PNEXF
38 027 714.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.6
34%
0.3
US
E
Epizyme Inc
F:EPE
1 852.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.2
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
JP
N
Noile-Immune Biotech Inc
TSE:4893
Average P/E: 211.7
Negative Multiple: -6.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 740.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61.1
413%
0.1
US
Amgen Inc
NASDAQ:AMGN
33.5
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
915.4
77%
11.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -213.4
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.7 N/A N/A
AU
CSL Ltd
ASX:CSL
31.8
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -134.7 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
N
Noile-Immune Biotech Inc
TSE:4893
Average EV/EBITDA: 16.2
Negative Multiple: -1.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 476 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.8 N/A N/A
AU
CSL Ltd
ASX:CSL
19.7
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.1
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.8 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -108.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
N
Noile-Immune Biotech Inc
TSE:4893
Average EV/EBIT: 21.2
Negative Multiple: -1.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 971.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.4
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.1
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.1 N/A N/A
AU
CSL Ltd
ASX:CSL
24.6
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.7
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -79.3 N/A N/A

See Also

Discover More
Back to Top